BHCG Monitor: Focus on Health Care Benefits

April 2016

In this issue:



This is your publication – so please let us know what you think! If there are future topics you'd like to see covered in these pages or if you've read something that you'd like to share with other readers, please email Jennifer LaMere at with your suggestions.

All issues of the Monitor can be found at: BHCG Newsletters.

Find us on: LinkedIn | Facebook | Twitter


BHCG Monitor: Health Care Reform - Notable News


Health Care Reform – Notable News

Two-Year Delay for Cadillac Tax

The ACA provision everyone loves to hate – the so-called Cadillac tax – was delayed by two years via a bipartisan funding bill passed by Congress last December. The tax, originally set to go into effect in 2018, imposes a 40 percent levy on high-cost employer-sponsored health plans. Delaying the tax until 2020 easily won support by Congress. Its ultimate fate will now be in the hands of a new Congress and president.

Although considered a win for employers, the delay does not change the fact the tax is still part of the law. None of the current presidential candidates support the tax. However, until it’s repealed altogether, employers need to be ready to comply or pay the price for high-cost plans ($10,200 for individuals, $27,500 for families) come 2020.


BHCG Monitor: An Electronic Personal Health Record Primer


Generic Drugs Skyrocketing Out of the Bargain Bin

Generic drugs account for about 80 percent of all prescriptions in the United States. Employers have been controlling their prescription drugs costs for years by aggressively encouraging the use of generic drugs. And with good reason – generic drugs are often 85 to 90 percent less expensive than their brand name counterparts prior to patent expiration. Many say the competitive market for generic medications has been a key driver in keeping overall health care costs in check.

However, across the country, the more than 60 percent of Americans taking prescription drugs are refilling prescriptions only to find the cost for generic drugs has double, tripled and in some cases spiked 1,000 percent or more. Concerns about the rising cost of prescription drugs (the fastest growing component of health care costs) have been most recently focused on specialty drug treatments that can cost tens, and sometimes hundreds of thousands of dollars per patient. But, because of the sheer volume of their use, recent skyrocketing prices of generic drugs have caught the attention of payers of all stripes.